Clinical trials
End Stage Renal Failure on Dialysis clinical trials
Below are recruiting end stage renal failure on dialysis clinical trials, each written for real people, not researchers. We’re tracking 42 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07033273Recruiting
Ultrasound vein test to predict low blood pressure during dialysis
This study uses an ultrasound to check how much your main vein (inferior vena cava) collapses during dialysis. It aims to see if this measurement can help predict drops in blood pressure during treatment, so doctors can better manage your dialysis sessions.
Wuhu, AnhuiAges 18–80 - NCT05738525Recruiting
Compare two types of home dialysis for kidney outcomes and quality of life
This study compares two forms of home peritoneal dialysis—how well they work for kidney health and how they affect daily life. You may be considered if you have end-stage kidney disease and meet specific test and safety requirements.
Beijing, Beijing MunicipalityAges 18–75 - NCT05917795Recruiting
Endoscopic stomach reduction for weight loss before kidney transplant
This trial tests an endoscopic procedure that helps reduce stomach size to support weight loss in people with severe kidney disease who may need a kidney transplant. It may help some patients meet transplant-center weight requirements and potentially improve readiness for transplant care.
RomeAges 18–70 - NCT06224140Recruiting
Dialysis without heparin: a safety study
This study tests whether dialysis can be done safely without using heparin (a blood thinner) in people with end-stage kidney disease. If successful, it could reduce the need for blood-thinning medications and their associated risks.
Marseille, Bouches du RhôneAges 18 years+ - NCT06408077Recruiting
How sodium levels are managed in kidney failure
This study looks at how the body handles salt (sodium) in people with end-stage kidney disease who are on dialysis. If you join, researchers will test how your body responds to changes in fluids and salt levels.
CologneAges 18 years+ - NCT07591714Recruiting
Eye Exercises During Dialysis Treatment
This study tests whether simple eye exercises done during your regular hemodialysis sessions can help improve eye health and comfort. Researchers will teach you easy eye movements to practice while you're hooked up to your dialysis machine.
IsfahanAges 18–80 - NCT06982573Recruiting
Magnetic Stimulation for Low Back Pain in Dialysis Patients
This trial tests whether magnetic stimulation can help relieve low back pain and help maintain muscle mass in people with end-stage kidney disease who are on dialysis. It is for those who have moderate to severe low back pain and are otherwise healthy enough for the procedure.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT07216885Recruiting
Testing a new hemodialysis machine in a dialysis center
This study tests a new dialysis machine called the Solv Multi-Pass System in a dialysis center. It looks at whether the machine works safely and effectively for people with end-stage kidney disease who need regular hemodialysis.
Greenville, South CarolinaAges 18 years+ - NCT06660277Recruiting
Dialysis with expanded solute removal study
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
London, OntarioAges 45 years+ - NCT06902896RecruitingPhase 1/Phase 2
FAP iCDC therapy for advanced heart failure from dilated cardiomyopathy
This trial tests a new treatment called FAP iCDC for people with end-stage dilated cardiomyopathy, a type of heart muscle disease. It aims to see if this therapy is safe and helps improve heart function when standard medicines are no longer enough.
Hangzhou, ZhejiangAges 18–75 - NCT07516288RecruitingPhase 1
Second CAR-DC Cell Infusion for Advanced Heart Failure
This trial tests a second dose of specialized immune cells (called CAR-DC) in patients with severe dilated cardiomyopathy (a weakened heart muscle) who received one dose before but saw their heart function decline back to baseline. The goal is to see if a second dose is safe and can improve heart function when the first treatment's benefits wore off.
Hangzhou, Zhejiang / 浙江Ages 18–75 - NCT07626710Recruiting
How Heart Valve Replacement Affects Kidney Function
This study looks at whether a minimally invasive heart valve procedure (TAVI) affects how well your kidneys work. Researchers will track your kidney function before and after the procedure using blood tests to understand any changes.
Roma, RMAges 18 years+ - NCT06455280RecruitingPhase 1
A study of Siplizumab for autoimmune liver disease patients awaiting transplant
This trial tests a drug called Siplizumab in people with autoimmune hepatitis or primary sclerosing cholangitis who are on the liver transplant waitlist. It aims to see if the drug can help manage their condition before and after transplant.
New York, New YorkAges 18 years+ - NCT06750575Recruiting
Study of furosemide on toxin removal in chronic kidney disease
This study tests whether the water pill furosemide can help remove certain toxins from the blood in people with chronic kidney disease (CKD stages 3-5) who are starting this medicine as part of their regular care.
Utrecht, UtrechtAges 18 years+ - NCT06823713RecruitingPhase 1/Phase 2
Engineered immune cells for liver cirrhosis
This trial tests a personalized cell therapy made from your own white blood cells (called macrophages) that are engineered to help reduce scarring and inflammation in the liver. It is for people with liver cirrhosis due to fatty liver disease who have recently had a serious liver complication or need frequent fluid drainage.
BarcelonaAges 18–75 - NCT04626167RecruitingEarly Phase 1
Testing a bladder transplant done with a kidney transplant
This early-phase study is testing a combined bladder and kidney transplant approach for people whose bladder problems damage the kidneys. The goal is to see if this treatment can improve bladder and kidney outcomes and be done safely.
Rochester, MinnesotaAges 1–60 - NCT07151742Enrolling by invitation
Exercise during dialysis for muscle health
This study tests whether exercise during hemodialysis can improve muscle oxygen levels and how well dialysis works. It is for people who have been on dialysis for at least a year and have muscle loss (sarcopenia).
Istanbul, KadikoyAges 18–65 - NCT06369064Recruiting
Comparing dialysis methods for kidney injury in the ICU
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
NîmesAges 18 years+
Hear when a new End Stage Renal Failure on Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for end stage renal failure on dialysis?
- Yes. Clin2 currently lists 42 recruiting end stage renal failure on dialysis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a end stage renal failure on dialysis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a end stage renal failure on dialysis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.